InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by BIOTECH GROWTH N V. Insider active across 2 companies, notably ESSA Pharma Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €5.2m. The latest transaction was disclosed on 27 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€378,471150,000 shares@ €2.52310.27% mcap28.9% of flow
Common Stock
SEC:0000899243-22-016006:0·
Ideal exit: 22 Jan 2023 (T+270)
€139,19925,100 shares@ €5.54583.5% of flow
Common Shares
SEC:0000899243-22-015831:0·
€458,120150,000 shares@ €3.05410.33% mcap34.9% of flow
Common Stock
SEC:0000899243-22-015145:0·
Ideal exit: 13 Jan 2023 (T+270)
€474,407150,000 shares@ €3.16270.34% mcap36.2% of flow
Common Stock
SEC:0000899243-22-014768:0·
Ideal exit: 7 Jan 2023 (T+270)
€2m250,000 shares@ €7.5835100.0% of flow
Common Shares
SEC:0000899243-21-033765·
Ideal exit: 15 May 2022 (T+270)
€2m250,000 shares@ €7.583548.2% of flow
Common Shares
SEC:0000899243-21-033765:0·
Ideal exit: 15 May 2022 (T+270)
6 of 6 declarations
About BIOTECH GROWTH N V
BIOTECH GROWTH N V is a director at ESSA Pharma Inc. and is also associated with Black Diamond Therapeutics, Inc.
